3 Recruiting Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 Phase 2 Clinical Trials

Active phase 2 studies for clinical stage iv hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 enrolling across the USA. Verify eligibility and contact site coordinators.

All Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 studies

Phase 2 Studies for Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8

🔵 Active, Not Recruiting Phase2 / Phase3

Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers

📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase2

Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio

View Study & Checklist ➔

🟢 Recruiting Phase2

Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial

📍 Emory University Hospital Midtown — Atlanta, Georgia

View Study & Checklist ➔